{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:07Z","timestamp":1759336207441,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.gastrohep.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T16:51:50Z","timestamp":1571676710000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Limitaciones de la determinaci\u00f3n de calprotectina fecal en pacientes con colitis ulcerosa y p\u00f3lipos inflamatorios"],"prefix":"10.1016","volume":"43","author":[{"given":"Fernando","family":"Bermejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bonillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Guardiola-Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2019.08.003_bib0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.gastrohep.2012.10.008","article-title":"Calprotectina fecal en el diagn\u00f3stico de enfermedades inflamatorias","volume":"36","author":"Rodr\u00edguez-Moranta","year":"2013","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5009\/gnl17445","article-title":"Fecal immunochemical test and fecal calprotectin measurement are noninvasive monitoring tools for predicting endoscopic activity in patients with ulcerative colitis","volume":"12","author":"Young","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756283X17744739","article-title":"Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin","volume":"11","author":"Derwa","year":"2018","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0220","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.2008.170019","article-title":"Monitoring disease activity by stool analyses: From occult blood to molecular markers of intestinal inflammation and damage","volume":"58","author":"Foell","year":"2009","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0225","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.gastrohep.2018.05.029","article-title":"Recomendaciones del Grupo Espa\u00f1ol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinaci\u00f3n de calprotectina fecal en la enfermedad inflamatoria intestinal","volume":"41","author":"Guardiola","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0230","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3109\/00365521.2014.934913","article-title":"Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders","volume":"49","author":"Caviglia","year":"2014","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000476062","article-title":"Calprotectin in daily practice: Where do we stand in 2017?","volume":"95","author":"D\u2019Angelo","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474124.2014.869476","article-title":"The use of fecal calprotectin as a biomarker in gastrointestinal disease","volume":"8","author":"Burri","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0245","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3109\/00365521.2013.816771","article-title":"Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care","volume":"48","author":"Pavlidis","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0250","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1053\/j.gastro.2005.03.031","article-title":"A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine","volume":"128","author":"L\u00e9mann","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0255","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ibd.21445","article-title":"Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity","volume":"17","author":"Regueiro","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0260","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.3399\/bjgp16X685645","article-title":"Faecal calprotectin in patients with suspected colorectal cancer: A diagnostic accuracy study","volume":"66","author":"Turvill","year":"2016","journal-title":"Br J Gen Pract."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10620-007-9820-6","article-title":"Fecal calprotectin in patients with colonic polyposis","volume":"53","author":"Pezzilli","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224770","article-title":"Solitary juvenile polyp as a cause of elevated faecal calprotectin in an adult","author":"Hodgson-Parnell","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MPG.0000000000000893","article-title":"Value of fecal calprotectin as a biomarker for juvenile polyps in children investigated with colonoscopy","volume":"62","author":"Olafsdottir","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1148\/radiographics.11.2.2028064","article-title":"Polypoid and pseudopolypoid manifestations of inflammatory bowel disease","volume":"11","author":"Buck","year":"1991","journal-title":"Radiographics"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0285","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3748\/wjg.v23.i9.1541","article-title":"Pseudopolyps in inflammatory bowel diseases: Have we learned enough?","volume":"23","author":"Politis","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF02627260","article-title":"Pseudopolyps in ulcerative colitis","volume":"8","author":"Goldgraber","year":"1965","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(69)90260-8","article-title":"Pseudopolyposis in ulcerative colitis","volume":"2","author":"Jalan","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0300","first-page":"389","article-title":"The surgical pathology of ulcerative colitis","volume":"14","author":"Dukes","year":"1954","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0305","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00000478-198606000-00007","article-title":"Giant and symptomatic inflammatory polyps of the colon in idiopathic inflammatory bowel disease","volume":"10","author":"Kelly","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF02556166","article-title":"The pathogenesis of inflammatory polyps","volume":"30","author":"Kelly","year":"1987","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0315","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2214\/ajr.113.2.325","article-title":"The overlapping spectrum of ulcerative and granulomatous colitis: A roentgenographic-pathologic study","volume":"113","author":"Margulis","year":"1971","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0320","first-page":"159","article-title":"Course and prognosis of ulcerative colitis","volume":"88","author":"Chawla","year":"1990","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0325","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000200623","article-title":"Life history of nonspecific ulcerative colitis: Relation of prognosis to anatomical and clinical varieties","volume":"86","author":"Bockus","year":"1956","journal-title":"Gastroenterologia"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0330","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.5858\/2004-128-1286-DGIPAC","article-title":"Diffuse giant inflammatory polyposis: A challenging clinicopathologic diagnosis","volume":"128","author":"Sheikholeslami","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0335","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.1.5501.1442","article-title":"Local complications of ulcerative colitis: Stricture, pseudopolyposis, and carcinoma of colon and rectum","volume":"1","author":"De Dombal","year":"1966","journal-title":"Br Med J"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.1968.03140300066022","article-title":"Localized giant pseudopolyps of the colon","volume":"205","author":"Hinrichs","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0345","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"Annese","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0350","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.gastrohep.2018.07.012","article-title":"Gu\u00eda de pr\u00e1ctica cl\u00ednica. Diagn\u00f3stico y prevenci\u00f3n del c\u00e1ncer colorrectal. Actualizaci\u00f3n 2018","volume":"41","author":"Cubiella","year":"2018","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0355","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.gie.2006.12.016","article-title":"Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: An Internet-based study","volume":"66","author":"Farraye","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0360","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Metaanalysis: Fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0365","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: A systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0370","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D\u2019Haens","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0375","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/MIB.0b013e3182802b6e","article-title":"A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis","volume":"19","author":"Lobat\u00f3n","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0380","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.dld.2017.12.022","article-title":"Accuracy of fecal calprotectina for the prediction of endoscopic activity in patients with inflammatory bowel disease","volume":"50","author":"Jusu\u00e9","year":"2018","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0385","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ibd.20933","article-title":"Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0390","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease","volume":"54","author":"Costa","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0395","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1097\/MIB.0b013e31829b2a37","article-title":"Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy","volume":"19","author":"De Vos","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.08.003_bib0400","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/00365521.2017.1410219","article-title":"Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission","volume":"53","author":"Garcia-Planella","year":"2018","journal-title":"Scand J Gastroenterol."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570519301980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570519301980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:43:03Z","timestamp":1759322583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570519301980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0210570519301980"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2019.08.003","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limitaciones de la determinaci\u00f3n de calprotectina fecal en pacientes con colitis ulcerosa y p\u00f3lipos inflamatorios","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}